Literature DB >> 14594176

Y chromosome sequences in Turner's syndrome: association with virilization and gonadoblastoma.

E E Mancilla1, H Poggi, G Repetto, H Rumié, H García, F Ugarte, S Hidalgo, A Jara, S Muzzo, E Panteón, I Torrealba, A Foradori, A Cattani.   

Abstract

UNLABELLED: The presence of Y chromosome fragments in patients with Turner's syndrome is known to increase the risk of gonadoblastoma and virilization. Y chromosome material is detected in up to 6% of patients with Turner's syndrome by karyotype. By DNA analysis, Y chromosome sequences have been reported in 0-60% of patients. The putative gonadoblastoma gene has been mapped to the pericentromeric region of the Y chromosome increasing the interest in studying these sequences. AIMS: 1. To determine the frequency of occult Y chromosome sequences in patients with Turner's syndrome. 2. To analyze the clinical implications of Y sequences detected by karyotype and occult Y sequences. STUDY
DESIGN: Cross-sectional study of 58 patients with Turner's syndrome (30 45,X; two with structural anomalies; 26 mosaic [two of whom were 45,X/46,XY]). SRY, TSPY and DYZ3 sequences were amplified by PCR using genomic DNA from peripheral blood.
RESULTS: All three Y chromosome sequences were found in one out of 56 patients whose karyotype was not suggestive of having Y chromosome material and in one patient with 45,X/46,Xr(X) karyotype. The patients with the ring chromosome and 45,X/46,XY karyotype underwent surgery and were found to have a gonadoblastoma and dysgerminoma. The four patients with Y chromosome material had non-virilized female genitalia.
CONCLUSIONS: Analysis by PCR was more sensitive in detecting Y chromosome sequences than conventional karyotype. The presence of Y material was not associated with virilization. We confirmed the association of Y fragments and gonadoblastoma at an early age.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14594176     DOI: 10.1515/jpem.2003.16.8.1157

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

1.  Dysgerminoma in a female with turner syndrome and Y chromosome material: A case-based review of literature.

Authors:  Sunil Kumar Kota; Kotni Gayatri; Jaya Prakash Pani; Siva Krishna Kota; Lalit Kumar Meher; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2012-05

2.  Primitive neuroectodermal tumor of the brain in a girl with Turner syndrome diagnosed after 4 years of growth hormone therapy.

Authors:  Shih-Hsiang Chen; Chia-Sui Hung; Fu-Sung Lo; Huei-Shyong Wang; Shih-Ming Jung; Tai-Ngar Lui
Journal:  Eur J Pediatr       Date:  2006-02-01       Impact factor: 3.183

3.  Risk of Gonadoblastoma Development in Patients with Turner Syndrome with Cryptic Y Chromosome Material.

Authors:  Ahreum Kwon; Sei Eun Hyun; Mo Kyung Jung; Hyun Wook Chae; Woo Jung Lee; Tae Hyuk Kim; Duk Hee Kim; Ho-Seong Kim
Journal:  Horm Cancer       Date:  2017-03-27       Impact factor: 3.869

Review 4.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

5.  Human Y-chromosome variation and male dysfunction.

Authors:  Cláudia Márcia Benedetto de Carvalho; Fabrício Rodrigues Santos
Journal:  J Mol Genet Med       Date:  2005-12-06

6.  The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors.

Authors:  Yunmin Li; Z Laura Tabatabai; Tin-Lap Lee; Shingo Hatakeyama; Chikara Ohyama; Wai-Yee Chan; Leendert H J Looijenga; Yun-Fai Chris Lau
Journal:  Hum Pathol       Date:  2007-05-22       Impact factor: 3.466

7.  Hepatocellular Carcinoma, Virilization, and Hilus Cell Hyperplasia in a Girl With Turner Syndrome.

Authors:  Jennifer R Law; Sang Lee; Eizaburo Sasatomi; Christine E Bookhout; Julie Blatt
Journal:  J Endocr Soc       Date:  2018-04-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.